Moreover , IFN -2 b also contributed to improved vasomotor symptoms in MPDs , and especially significantly decreased the incidence of distal paresthesias ( 14.1 % versus 37.5 % ) and erythromelalgia ( 9.4 % versus 29.2 % ) better than HU ( P < 0.01 ) .